Our Pricing

Buy Wegovy Private Prescription - Skip NHS Queues

Published on: June 03, 2026

When you buy Wegovy private prescription through Cured Pharmacy, you access UK-licensed semaglutide injections from £79.00 without NHS waiting lists. Our UK-registered clinical team provides free online consultations in under 3 minutes, with discreet next-day delivery across the UK.

How Wegovy Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone glucagon-like peptide-1 in your body [1]. This medication works by slowing gastric emptying, reducing appetite signals to the brain, and improving blood sugar regulation — three mechanisms that support sustained weight reduction when combined with lifestyle modifications.

In the landmark STEP 1 trial involving 1,961 adults with obesity, participants using Wegovy achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [2]. Importantly, 86.4% of Wegovy participants lost at least 5% of their baseline weight, meeting the clinical threshold for meaningful health benefits [2].

Wegovy is administered as a once-weekly subcutaneous injection, starting at 0.25mg and gradually escalating to a maintenance dose of 2.4mg over 16-20 weeks [3]. This dose titration schedule minimises gastrointestinal side effects whilst allowing your body to adapt to the medication's metabolic effects.

Why Choose Private Prescription Over NHS

NHS Wegovy prescriptions currently face significant supply constraints and strict eligibility criteria limiting access to patients with BMI ≥35 plus weight-related complications, or BMI ≥30 with specific comorbidities [4]. Even when eligible, waiting times can extend beyond 6-12 months in many UK regions due to commissioning restrictions and formulary limitations.

A private Wegovy prescription through Cured Pharmacy removes these barriers entirely. Our UK-registered prescribers assess your individual circumstances during a confidential online consultation, applying clinical judgement rather than rigid NHS commissioning guidelines. You'll receive a decision within hours, not months, with medication dispatched the same day when approved.

Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription dispensed from our GPhC-registered pharmacy (9012511), ensuring the same regulatory standards as high-street pharmacies whilst offering transparent upfront pricing and 100% discreet packaging.

Eligibility for Private Wegovy Prescription

Private prescribers typically consider Wegovy for adults with BMI ≥30, or BMI ≥27 with weight-related health conditions such as type 2 diabetes, hypertension, or obstructive sleep apnoea. Your prescriber will review your medical history, current medications, and weight loss goals during the online consultation to determine suitability. Wegovy is not appropriate for patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease [3].

Wegovy Dosing Schedule and What to Expect

Wegovy follows a structured dose escalation protocol designed to optimise tolerability whilst achieving therapeutic effect. You'll begin with 0.25mg weekly for four weeks, then increase every four weeks through 0.5mg, 1mg, and 1.7mg, before reaching the maintenance dose of 2.4mg at week 17 [3].

Most patients notice appetite reduction within the first two weeks, though significant weight loss typically becomes evident after 8-12 weeks on the escalating doses. Clinical trial data shows the majority of weight loss occurs within the first 60 weeks of treatment, with weight stabilisation thereafter when combined with sustained lifestyle modifications [2].

Common initial side effects include nausea, diarrhoea, and constipation, affecting approximately 44%, 30%, and 24% of users respectively in clinical trials [2]. These gastrointestinal effects usually diminish within 4-8 weeks as your body adapts. Taking Wegovy on the same day each week, staying well-hydrated, and eating smaller meals can help manage these temporary symptoms.

Injection Technique and Storage

Wegovy pens are pre-filled and designed for self-administration into the abdomen, thigh, or upper arm. Each pen delivers a single dose and should be stored in the refrigerator between 2-8°C until use. Your first prescription includes detailed NHS-approved injection guidance, and our clinical team remains available via phone (+44 116 4646009) for any technique questions during your treatment journey.

Wegovy Private Prescription Cost at Cured Pharmacy

At Cured Pharmacy, Wegovy starts from £79.00 per pen with transparent pricing displayed before you complete your clinical consultation. This represents competitive UK pricing with no hidden fees — the price you see includes the medication, UK prescriber assessment, and discreet delivery to your preferred address.

Your initial prescription typically covers the dose escalation phase, with subsequent prescriptions adjusted to your maintenance dose and treatment response. Unlike some providers who bundle mandatory subscription models, Cured Pharmacy offers flexible ordering so you maintain complete control over your treatment timeline and budget.

We guarantee lowest prices in the UK market, and all Wegovy supplied is sourced directly from UK-licensed wholesalers with full MHRA traceability. You'll never receive parallel imports or unlicensed formulations — only genuine Novo Nordisk Wegovy as approved for use in the United Kingdom.

How to Buy Wegovy Private Prescription Online

The entire process takes under 10 minutes from start to delivery. Begin by completing our free online medical questionnaire, which asks about your weight history, current health conditions, medications, and weight loss goals. This information is reviewed by a UK-registered prescriber who will assess your suitability for Wegovy based on current MHRA licensing and clinical guidelines.

If approved, your prescription is sent electronically to our GPhC-registered pharmacy where it's dispensed the same working day. Wegovy is shipped in temperature-controlled packaging to maintain the cold chain required for semaglutide stability, with tracking provided via SMS and email.

Should the prescriber determine Wegovy isn't appropriate for your circumstances, they may suggest alternative treatments or recommend follow-up with your NHS GP for additional investigations. No payment is taken until a prescription is issued, ensuring complete transparency throughout the clinical assessment process.

What Happens After Your First Prescription

After four weeks on your starting dose, you'll need a follow-up prescription for the next dose tier. Our clinical team will contact you to arrange this, checking for any side effects or concerns before progressing. This staged approach ensures safe dose escalation and allows your prescriber to monitor treatment response at each phase. Most patients remain on Wegovy for 12-24 months to achieve and consolidate their weight loss goals, though treatment duration is individualised based on clinical response and tolerability.

Wegovy vs Other Weight Loss Injections

Wegovy belongs to the GLP-1 receptor agonist class, which also includes Saxenda (liraglutide) and Ozempic (semaglutide at lower doses for type 2 diabetes). While these medications share similar mechanisms, Wegovy's once-weekly dosing and higher semaglutide concentration deliver superior weight loss outcomes compared to daily Saxenda injections [5].

Newer dual-action treatments targeting both GLP-1 and GIP receptors have emerged, showing even greater weight reduction in head-to-head trials. However, Wegovy remains the most extensively studied GLP-1 treatment for weight management, with over 4,500 participants across the STEP clinical trial programme providing robust long-term safety and efficacy data [2][6].

Your prescriber will discuss which injectable treatment best suits your medical history, lifestyle preferences, and budget. Some patients prefer daily injections for more consistent appetite control, whilst others value the convenience of once-weekly administration. There's no single 'best' option — the right choice depends on your individual circumstances and treatment goals.

Scientific References

1. Knudsen, L. B., & Lau, J. (2019). The Discovery and Development of Liraglutide and Semaglutide. Frontiers in Endocrinology, 10, 155. https://doi.org/10.3389/fendo.2019.00155 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Novo Nordisk. (2023). Wegovy 2.4 mg Solution for Injection in Pre-filled Pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Semaglutide for Managing Overweight and Obesity [TA875]. NICE. Retrieved from https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
5. O'Neil, P. M., Birkenfeld, A. L., McGowan, B., et al. (2018). Efficacy and Safety of Semaglutide Compared With Liraglutide and Placebo for Weight Loss in Patients With Obesity: A Randomised, Double-Blind, Placebo and Active Controlled, Dose-Ranging, Phase 2 Trial. The Lancet, 392(10148), 637–649. https://doi.org/10.1016/S0140-6736(18)31773-2 [accessed 13 August 2026]
6. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.